Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T05:02:20.135Z Has data issue: false hasContentIssue false

CSF Neuropeptides in Euthymic Bipolar Patients and Controls

Published online by Cambridge University Press:  02 January 2018

Wade H. Berrettini*
Affiliation:
Intramural Research Program
John I. Nurnberger Jr.
Affiliation:
Intramural Research Program
Robert L. Zerbe
Affiliation:
Lilly Research Centre, Ltd, Surrey, UK
Philip W. Gold
Affiliation:
IRP NIMH, National Institute of Health, Bethesda
George P. Chrousos
Affiliation:
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda
Thomas Tomai
Affiliation:
IRP NIMH, National Institute of Health, Bethesda
*
∗ National Institute of Mental Health, Bethesda, Maryland 20205, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Levels of vasopressin, somatostatin, neurotensin, vasoactive intestinal peptide, corticotrophin-releasing factor and adrenocorticotrophin in CSF were determined in lithium-treated and unmedicated euthymic bipolar patients and controls, in a search for a trait marker in affective disorder. No group differences in levels of these peptides were found. Highly significant positive correlations were found among these peptides (with the exception of neurotensin), suggesting that their presence in CSF is functionally significant, as opposed to the result of random diffusion from the interstitial space of the brain.

Information

Type
Research Article
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.